SCHEMBL19148564

SCHEMBL19148564

CC(=Nc1ccc(C(F)(F)F)cc1)C(F)F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.55
HTR3B O95264 1/20 0.55
PLAU P00749 1/20 0.55
HTR3A P46098 1/20 0.55
HTR3D Q70Z44 1/20 0.55
HTR3C Q8WXA8 1/20 0.55
NOS1 P29475 6/20 0.50
NOS3 P29474 4/20 0.50
NOS2 P35228 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
BLM P54132 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
KIF11 P52732 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20657394 1.00 HTR3E (0.55) HTR3EHTR3BPLAUHTR3AHTR3D
SCHEMBL20657453 0.79 HTR3E (0.60) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL20657448 0.79 HTR3E (0.60) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL19150084 0.78 NOS1 (0.59) PLAUNOS1NOS3NOS2LMNA
SCHEMBL20657395 0.78 NOS1 (0.59) PLAUNOS1NOS3NOS2LMNA
SCHEMBL19150085 0.77 NOS3 (0.51) NOS1NOS3NOS2ALDH1A1BLM
SCHEMBL20657417 0.77 NOS3 (0.51) NOS1NOS3NOS2ALDH1A1BLM
SCHEMBL20657618 0.75 NOS1 (0.54) HTR3EHTR3BPLAUHTR3AHTR3D
SCHEMBL19150099 0.75 NOS1 (0.54) HTR3EHTR3BPLAUHTR3AHTR3D
SCHEMBL18543991 0.74 HTR3E (0.57) HTR3EHTR3BPLAUHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-04-23 US disclosed
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-24 US disclosed
EP-3405458-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES Bayer CropScience Aktiengesellschaft (DE) 2018-11-28 EP disclosed
WO-2017125318-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES KCNQ1, KCNQ2, KCNQ4 HTR3E 1006/4885HTR3B 571/4885PLAU 4191/4885
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines KCNQ1, KCNQ2, KCNQ4 HTR3E 1006/4885HTR3B 571/4885PLAU 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.